Farther Finance Advisors, LLC Immunity Bio, Inc. Transaction History
Farther Finance Advisors, LLC
- $3.92 Trillion
- Q1 2025
A detailed history of Farther Finance Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 434 shares of IBRX stock, worth $1,167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
434
Previous 6
7133.33%
Holding current value
$1,167
Previous $15,000
8466.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IBRX
# of Institutions
236Shares Held
82.4MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$46.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$30.7 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$26.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$10.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$10.3 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.08B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...